Risankizumab Long-term Remission Study
Clinical trial NCT04630652 · COMPLETED
Trial details
- NCT number
- NCT04630652
- Sponsor
- Jaehwan Kim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2025-05-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.